248 related articles for article (PubMed ID: 16103884)
1. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.
Yu Q; Ciemerych MA; Sicinski P
Oncogene; 2005 Oct; 24(47):7114-9. PubMed ID: 16103884
[TBL] [Abstract][Full Text] [Related]
2. Mouse development and cell proliferation in the absence of D-cyclins.
Kozar K; Ciemerych MA; Rebel VI; Shigematsu H; Zagozdzon A; Sicinska E; Geng Y; Yu Q; Bhattacharya S; Bronson RT; Akashi K; Sicinski P
Cell; 2004 Aug; 118(4):477-91. PubMed ID: 15315760
[TBL] [Abstract][Full Text] [Related]
3. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.
Lovec H; Sewing A; Lucibello FC; Müller R; Möröy T
Oncogene; 1994 Jan; 9(1):323-6. PubMed ID: 8302597
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
Jiang W; Kahn SM; Zhou P; Zhang YJ; Cacace AM; Infante AS; Doi S; Santella RM; Weinstein IB
Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550
[TBL] [Abstract][Full Text] [Related]
6. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy.
Bartkova J; Rajpert-de Meyts E; Skakkebaek NE; Bartek J
J Pathol; 1999 Apr; 187(5):573-81. PubMed ID: 10398124
[TBL] [Abstract][Full Text] [Related]
7. Critical role for D-type cyclins in cellular transformation induced by E6/E7 of human papillomavirus type 16 and E6/E7/ErbB-2 cooperation.
Yasmeen A; Hosein AN; Yu Q; Al Moustafa AE
Cancer Sci; 2007 Jul; 98(7):973-7. PubMed ID: 17489986
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Cdk6-cyclin D3 highly sensitizes cells to physical and chemical transformation.
Chen Q; Lin J; Jinno S; Okayama H
Oncogene; 2003 Feb; 22(7):992-1001. PubMed ID: 12592386
[TBL] [Abstract][Full Text] [Related]
9. Malignant transformation by cyclin E and Ha-Ras correlates with lower sensitivity towards induction of cell death but requires functional Myc and CDK4.
Haas K; Johannes C; Geisen C; Schmidt T; Karsunky H; Blass-Kampmann S; Obe G; Möröy T
Oncogene; 1997 Nov; 15(21):2615-23. PubMed ID: 9399649
[TBL] [Abstract][Full Text] [Related]
10. Specific protection against breast cancers by cyclin D1 ablation.
Yu Q; Geng Y; Sicinski P
Nature; 2001 Jun; 411(6841):1017-21. PubMed ID: 11429595
[TBL] [Abstract][Full Text] [Related]
11. Crucial roles of D-type cyclins in the early stage of adipocyte differentiation.
Hishida T; Naito K; Osada S; Nishizuka M; Imagawa M
Biochem Biophys Res Commun; 2008 May; 370(2):289-94. PubMed ID: 18374658
[TBL] [Abstract][Full Text] [Related]
12. Development of mice expressing a single D-type cyclin.
Ciemerych MA; Kenney AM; Sicinska E; Kalaszczynska I; Bronson RT; Rowitch DH; Gardner H; Sicinski P
Genes Dev; 2002 Dec; 16(24):3277-89. PubMed ID: 12502747
[TBL] [Abstract][Full Text] [Related]
13. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.
Bartkova J; Lukas J; Müller H; Strauss M; Gusterson B; Bartek J
Cancer Res; 1995 Feb; 55(4):949-56. PubMed ID: 7850812
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D2 and cyclin D3 play opposite roles in mouse skin carcinogenesis.
Rojas P; Cadenas MB; Lin PC; Benavides F; Conti CJ; Rodriguez-Puebla ML
Oncogene; 2007 Mar; 26(12):1723-30. PubMed ID: 16983339
[TBL] [Abstract][Full Text] [Related]
15. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.
Ma Y; Feng Q; Sekula D; Diehl JA; Freemantle SJ; Dmitrovsky E
Cancer Res; 2005 Jul; 65(14):6476-83. PubMed ID: 16024653
[TBL] [Abstract][Full Text] [Related]
16. Alternative mammary oncogenic pathways are induced by D-type cyclins; MMTV-cyclin D3 transgenic mice develop squamous cell carcinoma.
Pirkmaier A; Dow R; Ganiatsas S; Waring P; Warren K; Thompson A; Hendley J; Germain D
Oncogene; 2003 Jul; 22(28):4425-33. PubMed ID: 12853979
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis.
Sicinski P; Donaher JL; Geng Y; Parker SB; Gardner H; Park MY; Robker RL; Richards JS; McGinnis LK; Biggers JD; Eppig JJ; Bronson RT; Elledge SJ; Weinberg RA
Nature; 1996 Dec; 384(6608):470-4. PubMed ID: 8945475
[TBL] [Abstract][Full Text] [Related]
18. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice.
Pasumarthi KB; Nakajima H; Nakajima HO; Soonpaa MH; Field LJ
Circ Res; 2005 Jan; 96(1):110-8. PubMed ID: 15576649
[TBL] [Abstract][Full Text] [Related]
19. Mnt transcriptional repressor is functionally regulated during cell cycle progression.
Popov N; Wahlström T; Hurlin PJ; Henriksson M
Oncogene; 2005 Dec; 24(56):8326-37. PubMed ID: 16103876
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1.
Tan A; Bitterman P; Sonenberg N; Peterson M; Polunovsky V
Oncogene; 2000 Mar; 19(11):1437-47. PubMed ID: 10723135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
